Who founded electroCore, Inc.?

electroCore, Inc. was founded by JP Errico.

Who are electroCore, Inc.'s investors?

electroCore, Inc.'s investors include Foothill Ventures, Tullis Health Investors, Merck Global Health Innovation Fund.

How much funding has electroCore, Inc. raised?

electroCore, Inc. has disclosed $86.8M raised across 10 of its 16 known rounds.

Where is electroCore, Inc. headquartered?

electroCore, Inc. is headquartered in Basking Ridge, US.

electroCore, Inc.

NASDAQ: ECOR

Basking Ridge, US · Delaware corporation · 3 known investors

Find your way into electroCore, Inc.

Paths you didn't know you had: your email and LinkedIn already hold routes to the electroCore, Inc. team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.

Biotech Digital Health Hardware Healthtech Medical Devices

Founders & leadership

JP Errico Founder · Board of Directors2019–2023JP Errico is a founder of electroCore who developed the company's intellectual property portfolio for vagus nerve stimulation. He holds an undergraduate degree in aeronautical engineering from MIT and graduate degrees in law and mechanical/materials engineering from Duke University, and has previously founded or held senior roles at multiple medical device and pharmaceutical companies.

Brian PosnerChief Financial Officer

Daniel S. GoldbergerExecutive

Peter StaatsChief Medical Officer

Frank Amato ExecutiveFrank Amato is a biotech and medical device executive who previously served as CEO of electroCore, where he led the commercialization of gammaCore and secured FDA clearances for the nVNS treatment. He has held senior leadership roles at major pharmaceutical companies including Merck, Schering Plough, Ligand Pharmaceuticals, Pfizer, and Pharmacia Corporation, and most recently served as CEO of Synaps Dx.

Board

Trevor MoodyBoard director

Jim Tullis Board directorFounding Partner at Tullis Health Investors

Peter CuneoBoard director

Julie A. GoldsteinBoard director

Thomas M. PattonBoard director

Thomas J. ErricoBoard director

John P. GandolfoBoard director

Investors · 3

Foothill Ventureslisted by Foothill VenturesLos Altos · $100K – $10M

How we know: Foothill Ventures's portfolio page · Not right? Tell us

Tullis Health Investorslisted by Tullis Health InvestorsPalm Beach Gardens · $500K – $10Mvia John Tullis · led

How we know: Tullis Health Investors's portfolio page · Not right? Tell us

Merck Global Health Innovation FundreportedRahway · $10M

How we know: the S-1 prospectus · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$86.8M disclosed across 10 of 16 rounds · 2016–2026

▶Undisclosed amountofferedApr 2026 · Other Health Care

Rule 506(b)